Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.27 - $0.5 $270 - $501
1,003 Added 1.06%
95,215 $27,000
Q1 2022

May 16, 2022

BUY
$0.37 - $0.54 $13,159 - $19,205
35,566 Added 60.65%
94,212 $43,000
Q4 2021

Feb 14, 2022

SELL
$0.34 - $0.86 $1,060 - $2,682
-3,119 Reduced 5.05%
58,646 $30,000
Q3 2021

Nov 15, 2021

BUY
$0.44 - $0.63 $22,722 - $32,533
51,641 Added 510.08%
61,765 $27,000
Q2 2021

Aug 11, 2021

SELL
$0.48 - $0.72 $147,582 - $221,373
-307,463 Reduced 96.81%
10,124 $6,000
Q1 2021

May 17, 2021

BUY
$0.68 - $1.25 $215,959 - $396,983
317,587 New
317,587 $219,000
Q2 2020

Aug 14, 2020

SELL
$0.41 - $0.73 $26,335 - $46,890
-64,234 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.36 - $0.79 $18,268 - $40,090
50,747 Added 376.27%
64,234 $27,000
Q4 2019

Feb 14, 2020

SELL
$0.75 - $0.89 $57,694 - $68,464
-76,926 Reduced 85.08%
13,487 $11,000
Q3 2019

Nov 14, 2019

SELL
$0.78 - $1.09 $8,361 - $11,684
-10,720 Reduced 10.6%
90,413 $82,000
Q2 2019

Aug 16, 2019

BUY
$0.98 - $1.64 $11,636 - $19,473
11,874 Added 13.3%
101,133 $117,000
Q2 2019

Aug 14, 2019

BUY
$0.98 - $1.64 $87,473 - $146,384
89,259 New
89,259 $103,000
Q4 2018

Feb 14, 2019

SELL
$0.63 - $1.0 $30,999 - $49,205
-49,205 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$0.88 - $1.1 $7,800 - $9,750
-8,864 Reduced 15.26%
49,205 $49,000
Q2 2018

Aug 14, 2018

BUY
$0.91 - $1.45 $52,842 - $84,200
58,069 New
58,069 $56,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About PALATIN TECHNOLOGIES INC


  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $9.01M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.